Ifp Advisors, Inc Pacific Biosciences Of California, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 1,000 shares of PACB stock, worth $1,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,000

Previous 1,000 -0.0%

Holding current value

$1,800

Previous $3,000 66.67%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	SELL	$8.23 - $13.93 $2,057 - $3,482	-250 Reduced 20.0%	1,000 $8,000
Q1 2023 Apr 18, 2023	SELL	$7.94 - $12.02 $12,704 - $19,232	-1,600 Reduced 56.14%	1,250 $14,000
Q4 2022 Feb 07, 2023	SELL	$5.67 - $11.2 $1,701 - $3,360	-300 Reduced 9.52%	2,850 $8,000
Q2 2022 Sep 06, 2022	BUY	$4.02 - $10.43 $12,662 - $32,854	3,150 New	3,150 $9,000
Q2 2022 Aug 12, 2022	SELL	$4.02 - $10.43 $12,662 - $32,854	-3,150 Closed	0 $0
Q1 2022 Sep 06, 2022	SELL	$8.43 - $20.9 $843 - $2,090	-100 Reduced 3.08%	3,150 $28,000
Q1 2022 Aug 08, 2022	BUY	$8.43 - $20.9 $843 - $2,090	100 Added 3.17%	3,250 $29,000
Q4 2021 Jan 12, 2022	SELL	$19.26 - $30.08 $8,667 - $13,536	-450 Reduced 12.5%	3,150 $63,000
Q3 2021 Oct 06, 2021	BUY	$24.86 - $35.02 $1,243 - $1,751	50 Added 1.41%	3,600 $92,000
Q2 2021 Jul 13, 2021	BUY	$22.3 - $36.02 $11,150 - $18,010	500 Added 16.39%	3,550 $124,000
Q1 2021 Apr 30, 2021	SELL	$26.38 - $51.15 $209,721 - $406,642	-7,950 Reduced 72.27%	3,050 $102,000
Q4 2020 Jan 25, 2021	BUY	$10.5 - $28.5 $10,500 - $28,500	1,000 Added 10.0%	11,000 $286,000
Q3 2020 Oct 29, 2020	BUY	$3.61 - $9.87 $18,050 - $49,349	5,000 Added 100.0%	10,000 $99,000
Q2 2020 Aug 05, 2020	SELL	$2.65 - $4.03 $98 - $149	-37 Reduced 0.73%	5,000 $17,000
Q1 2020 May 12, 2020	BUY	$2.36 - $5.26 $11,800 - $26,300	5,000 Added 13513.51%	5,037 $18,000
Q4 2019 Jan 17, 2020	SELL	$4.6 - $5.57 $919 - $1,114	-200 Reduced 84.39%	37 $0
Q3 2019 Nov 07, 2019	SELL	$4.99 - $6.16 $73,667 - $90,940	-14,763 Reduced 98.42%	237 $1,000
Q1 2019 May 15, 2019	SELL	$6.8 - $7.4 $55,732 - $60,650	-8,196 Reduced 35.33%	15,000 $108,000
Q4 2018 Jan 23, 2019	SELL	$3.99 - $7.82 $70,595 - $138,359	-17,693 Reduced 43.27%	23,196 $171,000
Q3 2018 Oct 25, 2018	BUY	$3.52 - $5.55 $3,696 - $5,827	1,050 Added 2.64%	40,889 $0
Q2 2018 Aug 07, 2018	SELL	$2.11 - $3.92 $35,753 - $66,424	-16,945 Reduced 29.84%	39,839 $0
Q1 2018 Jun 03, 2019	BUY	$2.05 - $3.23 $37,812 - $59,577	18,445 Added 48.11%	56,784 $150,000
Q1 2018 May 09, 2018	SELL	$2.05 - $3.23 $37,812 - $59,577	-18,445 Reduced 32.48%	38,339 $0
Q4 2017 Jan 24, 2018	SELL	$2.59 - $5.44 $1,165 - $2,448	-450 Reduced 0.79%	56,784 $0
Q3 2017 Oct 30, 2017	SELL	$3.2 - $5.57 $1,760 - $3,063	-550 Reduced 0.95%	57,234 $300,000
Q2 2017 Jun 03, 2019	SELL	N/A	-10,398 Reduced 15.25%	57,784 $206,000
Q1 2017 Jun 03, 2019	SELL	N/A	-16,560 Reduced 19.54%	68,182 $353,000
Q4 2016 Jun 03, 2019	SELL	N/A	-34,555 Reduced 28.97%	84,742 $322,000
Q2 2016 Jun 03, 2019	BUY	N/A	104,297 Added 695.31%	119,297 $839,000
Q1 2016 Jun 03, 2019	BUY	N/A	15,000	15,000 $108,000

Others Institutions Holding PACB

# of Institutions

253

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $405M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account